Research published in Retrovirology tells of promising results from a phase II trial of a new vaccine that has been created, the HIV-1 Tat vaccine.
Sophie graduated with a BSc in Biology from the University of Southampton before joining BioMed Central as an Editorial Assistant in 2013. She then worked as Community Manager here, facilitating the promotion of content published in journals, before leaving the company in 2016.
Latest posts by Sophie Marchant (see all)
- June blogs digest: irritable bowel syndrome, regenerative medicine, single cell omics, and more - 6th July 2016
- May blogs digest: conducting clinical trials, a quiz on plants, dealing with retractions, and more - 1st June 2016
- Fighting alcohol with alcohol: a Managed Alcohol Program in Ontario - 9th May 2016